PI11353 Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate (CAS No.: 142569-69-5)

Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate (CAS No.: 142569-69-5) Description

Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate is an organic compound with the molecular formula C28H24ClNO3 and is provided as a powder. It serves as a pharmaceutical intermediate characterised by its well-defined stereochemistry and functional groups. The compound's specific structure facilitates predictable reactivity, aiding precise incorporation into synthesis processes and ensuring consistent performance across chemical batches.

Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate (CAS No.: 142569-69-5) Applications

Pharmaceutical Synthesis
   - Used as an intermediate in drug synthesis to achieve controlled reactivity by leveraging its defined stereochemistry.
   - Applied in reaction optimisation studies to improve yield and reduce by-products, owing to its consistent chemical profile.

Chemical Research
   - Employed as a model compound in structural activity relationship studies, facilitating advancements in synthetic methodologies.
   - Utilised in academic research to explore reaction mechanisms and develop innovative pathways in medicinal chemistry.

Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate (CAS No.: 142569-69-5) Packing

The compound is packaged in moisture-proof, anti-static containers with an inert gas atmosphere to limit contamination and preserve its chemical integrity. The packaging employs cushioned inserts to prevent mechanical damage during transit. Storage guidelines recommend a stable, cool, and dry environment. Additional customisation on packaging, including labelling and compartmentalisation, is available upon request to suit laboratory or manufacturing needs.

Additional Information

Pharmaceutical intermediates such as this compound are integral to the development of synthetic pathways in drug manufacturing. Their structural specificity supports targeted chemical transformations that enhance the efficiency and reproducibility of synthesis processes. Researchers benefit from thorough analytical characterisation that ensures the material meets stringent purity criteria.

Understanding the structural features and reactivity patterns of such intermediates is crucial for optimising reaction conditions. Advances in analytical techniques continue to refine quality control, supporting higher precision in pharmaceutical production and associated research applications.